These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17679819)

  • 1. Obesity and insulin resistance as risk factors for chronic kidney disease.
    Whaley-Connell A; Pavey BS; Afroze A; Bakris GL
    J Cardiometab Syndr; 2006; 1(3):209-14; quiz 215-6. PubMed ID: 17679819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence.
    Lastra G; Manrique C; Sowers JR
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):365-73. PubMed ID: 17045222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between hyperinsulinemia, hypertension and progressive renal disease.
    El-Atat FA; Stas SN; McFarlane SI; Sowers JR
    J Am Soc Nephrol; 2004 Nov; 15(11):2816-27. PubMed ID: 15504934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin-angiotensin-aldosterone system intervention in the cardiometabolic syndrome and cardio-renal protection.
    Whaley-Connell A; Pavey BS; Chaudhary K; Saab G; Sowers JR
    Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):27-35. PubMed ID: 19124393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microalbuminuria and proximal tubule remodeling in the cardiometabolic syndrome.
    Hayden MR; Chowdhury NA; Witte L; Sowers JR
    J Cardiometab Syndr; 2006; 1(2):107-14. PubMed ID: 17679822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension and the cardiometabolic syndrome.
    Manrique C; Lastra G; Whaley-Connell A; Sowers JR
    J Clin Hypertens (Greenwich); 2005 Aug; 7(8):471-6. PubMed ID: 16103758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiometabolic syndrome and chronic kidney disease.
    Lastra G; Manrique C; McFarlane SI; Sowers JR
    Curr Diab Rep; 2006 Jun; 6(3):207-12. PubMed ID: 16898573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
    Chalmers L; Kaskel FJ; Bamgbola O
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the cardiometabolic syndrome.
    Sowers JR
    Clin Cornerstone; 2001; 4(2):17-23. PubMed ID: 11838324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players.
    Zimmet P; Boyko EJ; Collier GR; de Courten M
    Ann N Y Acad Sci; 1999 Nov; 892():25-44. PubMed ID: 10842650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of the factors of hypoxia and endothelial dysfunction in kidney injury in the presence of obesity].
    Galiamov MG; Saginova EA; Severova MM; Samokhodskaia LM; Krasnova TN; Sholomova VI; Sorokin IuD; Mukhin NA
    Ter Arkh; 2013; 85(6):31-7. PubMed ID: 23866596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistant hypertension in the high-risk metabolic patient.
    Chaudhary K; Buddineni JP; Nistala R; Whaley-Connell A
    Curr Diab Rep; 2011 Feb; 11(1):41-6. PubMed ID: 20941645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Insulin resistance and hyperinsulinemia--clinical aspects].
    Kozek E
    Przegl Lek; 1996; 53(9):647-52. PubMed ID: 8992530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications.
    Sarafidis PA; Ruilope LM
    Am J Nephrol; 2006; 26(3):232-44. PubMed ID: 16733348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cardiometabolic syndrome as a cardiovascular risk factor.
    Govindarajan G; Whaley-Connell A; Mugo M; Stump C; Sowers JR
    Am J Med Sci; 2005 Dec; 330(6):311-8. PubMed ID: 16355016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.
    Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S
    Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity-associated hypertension. Hyperinsulinemia and renal mechanisms.
    Hall JE; Brands MW; Hildebrandt DA; Mizelle HL
    Hypertension; 1992 Jan; 19(1 Suppl):I45-55. PubMed ID: 1730454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperinsulinaemia, insulin resistance, microalbuminuria and the risk of coronary heart disease.
    Yudkin JS
    Ann Med; 1996 Oct; 28(5):433-8. PubMed ID: 8949975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renal consequences of obesity].
    Laville M
    Nephrol Ther; 2011 Apr; 7(2):80-5. PubMed ID: 21208837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity-related renal injury in childhood.
    Savino A; Pelliccia P; Chiarelli F; Mohn A
    Horm Res Paediatr; 2010; 73(5):303-11. PubMed ID: 20389099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.